Data extraction was conducted by two independent reviewers using a standardized form encompassing author details, publication year, study type, employed techniques, number of patients, patient demographics (age), follow-up duration, treatment efficacy outcomes (tumor volume decrease, local pain relief using Visual Analog Scale (VAS), and local pain-free survival, referring to the period during which the patient remains free from pain after the intervention), and AEs graded following the guidelines of the Society of Interventional Radiology (SIR) [13] and the National Cancer Institute Common Terminology Criteria Adverse Events (CTCAE, version 4.0)
M.Ben-AzuB.AjayiA
It can inhibit the production of inflammatory factors and the activation of signaling pathways, thereby reducing redness, itching, and discomfort caused by inflammation
Excessive DSIP dosing typically causes headaches, grogginess, or paradoxical insomnia rather than dangerous effects